The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Cash Rich in a Cruddy Economy: The Perfect Storm for Technology Takeovers
The Takeover Trader Email – #262
By Louis Basenese
As the market plumb’s new depths, we have two choices. Either pack it in. Or keep hunting for opportunities. As you probably guessed, I’m opting for the latter. And for good reason…
Prices for most stocks – particularly small technology firms – are down significantly, below cash in many instances. Yet the titans of the industry – Oracle, Cisco, and Microsoft – are sitting cash heavy with $29.5 billion, $20.7 billion and $10.6 billion, respectively.
Like a proverbial kid in a candy store with a five-dollar bill, don’t expect it to last very long…
In the past year, Oracle made more than a few impulse buys, scooping up 10 smaller firms for a combined $750 million. And CEO Larry Ellison is an unashamed takeover addict, not interested in quitting.
At Cisco, CEO John Chambers recently remarked, “Cash is king, queen and the royal family” in a recession. No king sits idly on the throne.
Not to be outdone, Microsoft executive Chris Liddell recently said the buying opportunities have “probably never been better.” Not a comment one makes, unless they’re out shopping.
So today, let’s place our bets on the most like target for acquisition…
To continue reading and get all The Takeover Trader’s latest updates, subscribe today.
- M&A Activity: Discover Which Sector is Primed for M&A Action
- Bet on the Chip Leaders… Intel (INTC)
- Takeover Targets: 3 Steps To Finding Them & 3 Stocks For Any Portfolio
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed